ISN Webinar: A new horizon in IgA nephropathy treatment – B cell modulation through inhibition of APRIL/BAFF signaling

IgA nephropathy is one of the most common glomerular diseases worldwide. This webinar will explore the potential role of BAFF and APRIL in the management of IgA nephropathy (IgAN).

After reviewing IgAN pathogenesis and the role of BAFF and APRIL in IgAN, this webinar will then provide a comprehensive overview of current clinical trials and discuss the integration of BAFF/APRIL inhibition into future treatment paradigms in IgAN.

Learning objectives:

- Understand the potential role of BAFF and APRIL in IgAN
- Discuss how BAFF APRIL inhibition will be integrated into future treatment paradigms in IgAN
- Review current clinical trial data of BAFF/APRIL inhibition in IgAN

 This webinar is supported by